End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23,800 KRW | -.--% | -3.25% | -11.85% |
2023 | Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022. | CI |
2023 | Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022. | CI |
Sales 2015 | 162B 117M | Sales 2016 * | 177B 128M | Capitalization | 350B 253M |
---|---|---|---|---|---|
Net income 2015 * | 19B 13.72M | Net income 2016 * | 18B 13M | EV / Sales 2015 | 1.65 x |
Net cash position 2015 * | 26.3B 18.99M | Net cash position 2016 * | 19.04B 13.74M | EV / Sales 2016 * | 1.87 x |
P/E ratio 2015 |
12.6
x | P/E ratio 2016 * |
21.3
x | Employees | 665 |
Yield 2015 |
1.26% | Yield 2016 * |
1.01% | Free-Float | 52.41% |
1 week | -3.25% | ||
1 month | -3.64% | ||
3 months | +0.21% | ||
6 months | -1.65% | ||
Current year | -11.85% |
Managers | Title | Age | Since |
---|---|---|---|
Won-Ho Kang
CEO | Chief Executive Officer | 47 | - |
Duk-Young Kang
CEO | Chief Executive Officer | 77 | - |
Won-Tae Jeong
BRD | Director/Board Member | 61 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Duk-Young Kang
CEO | Chief Executive Officer | 77 | - |
Gui-Ja Kim
BRD | Director/Board Member | 67 | - |
Won-Ho Kang
CEO | Chief Executive Officer | 47 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 23,800 | -.--% | 19,395 |
24-05-30 | 23,800 | -0.42% | 12,331 |
24-05-29 | 23,900 | -0.62% | 14,833 |
24-05-28 | 24,050 | +0.21% | 15,703 |
24-05-27 | 24,000 | -2.44% | 47,855 |
End-of-day quote Korea S.E., May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-11.85% | 253M | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-9.58% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- A033270 Stock